The drug has anti-inflammatory and antiaggregatory action, stimulates the muscles of the bladder.
The active substances of the extract of the prostate are referred to the group of peptide bioregulators - cytomedines. These drugs are basic peptides with a molecular weight of 1 to 10 kDa.Low-molecular peptides of a para- or autocrine nature, perform the function of trans-specific intra- and intercellular messengers.
Prostate gland peptides reduce clotting time and increase antiaggregatory activity of the vascular wall, improve blood microcirculation, increase fibrinolytic activity of the blood, increase the contractile activity of detrusor myocytes in vivo, in vitro. Have immunomodulatory and immunostimulating effect, enhance the synthesis of antihistamines and antiserotonin antibodies.
The use of peptide bioregulators in the treatment of chronic prostatitis is the ability of these drugs to restore microcirculation, to have an indirect anti-inflammatory effect by enhancing the synthesis of antihistamine and antiserotonin antibodies, as well as their immunomodulating and immunostimulating effect.
Treatment of benign prostatic hyperplasia is based on the most important biological effect of cytomedins: organotropicity, which allows to regulate the processes of differentiation and function of cells in the organ from which they are isolated.